Funder: Burroughs Wellcome Fund
Due Dates: February 11, 2027, 3:00 p.m. EST (Full application)
Funding Amounts: $500,000 USD over five years ($100,000 per year)
Summary: Supports academic researchers developing innovative regulatory science tools, standards, and approaches to improve product evaluation and regulatory decision-making.
Key Information: Developing a new drug, device, biologic, or intervention cannot be the project's primary goal.
Description
The Burroughs Wellcome Fund’s Innovation in Regulatory Science Awards support research developing and evaluating tools, standards, and approaches to assess the safety, efficacy, quality, and performance of products affecting human health. The program seeks to strengthen evidence informing decisions by the FDA, Health Canada, and other regulatory or standards-setting bodies while protecting the public and maintaining public trust. Projects may address therapeutics, biologics, devices, diagnostics, food, consumer products, or other human-health and safety concerns.
Priorities include biomarkers, endpoints, regenerative medicine and gene therapy, artificial intelligence and machine learning, digital health, alternatives to animal testing, model-informed development, drug repurposing, and patient and consumer empowerment. BWF particularly encourages approaches that responsibly improve or accelerate regulated product development while preserving rigor, quality, and safety. Where relevant, projects should investigate biological and nonbiological causes of interindividual variation.
